Lista de obras -

Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome

artículo científico publicado en 2012

Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature

artículo científico publicado en 2007

Baseline Characteristics and Gender Differences in Prepubertal Children Treated with Growth Hormone in Europe, USA, and Japan: 25 Years' KIGS® Experience (1987-2012) and Review

artículo científico publicado en 2016

Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of d

artículo científico publicado en 2004

Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy.

artículo científico publicado en 2018

Early-onset idiopathic growth hormone deficiency within KIGS.

artículo científico publicado en 2003

Efficacy of Growth Hormone Treatment in Children with Type 1 Diabetes Mellitus and Growth Hormone Deficiency-An Analysis of KIGS Data.

artículo científico publicado en 2018

Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease

artículo científico publicado en 2008

Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone

artículo científico publicado en 2008

Final height in children with medulloblastoma treated with growth hormone

artículo científico publicado en 2005

Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database

artículo científico publicado en 2017

Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data fr

artículo científico publicado en 2010

Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome

artículo científico publicado en 2013

Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.

artículo científico publicado en 2005

Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone

artículo científico publicado en 2017

Insulin-like growth factors as diagnostic tools in growth hormone deficiency during childhood and adolescence: the KIGS experience.

artículo científico publicado en 2004

Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data

artículo científico publicado en 2014

Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.

artículo científico publicado en 2015

Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database).

artículo científico publicado en 2013

Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.

artículo científico publicado en 2007

Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables

artículo científico publicado en 2010

Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis an

artículo científico publicado el 25 de febrero de 2011

Predicting growth in response to growth hormone treatment

artículo científico publicado en 2008

Predicting the response to growth hormone treatment in short children with chronic kidney disease

artículo científico publicado en 2009

Prediction model of total pubertal growth in idiopathic growth hormone deficiency: analysis of data from KIGS.

artículo científico publicado en 2003

Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database) ⬇️

artículo científico publicado el 1 de junio de 2011

Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).

artículo científico publicado en 2003

Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment

artículo científico publicado en 2006

Secular Trends on Birth Parameters, Growth, and Pubertal Timing in Girls with Turner Syndrome.

artículo científico publicado en 2018

Short Children with CHARGE Syndrome: Do They Benefit from Growth Hormone Therapy?

artículo científico publicado en 2015

Stimulant use and its impact on growth in children receiving growth hormone therapy: an analysis of the KIGS International Growth Database.

artículo científico publicado en 2014

The Basis for Optimising Growth with Growth Hormone Usage in Children with Idiopathic Short Stature: Analysis of Data from KIGS (Pfizer International Growth Study Database) ⬇️

artículo científico publicado el 7 de septiembre de 2011

The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency

artículo científico publicado en 2003

Three-year growth response to growth hormone treatment in very young children born small for gestational age-data from KIGS.

artículo científico publicado en 2014

Towards optimal treatment with growth hormone in short children and adolescents: evidence and theses

artículo científico

Using a spontaneous profile rather than stimulation test makes the KIGS idiopathic growth hormone deficiency model more accessible for clinicians.

artículo científico publicado en 2017

Weight gain in Turner Syndrome: association to puberty induction? - longitudinal analysis of KIGS data

artículo científico publicado en 2016

Lista de obras de

Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome

Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature

Baseline Characteristics and Gender Differences in Prepubertal Children Treated with Growth Hormone in Europe, USA, and Japan: 25 Years' KIGS® Experience (1987-2012) and Review

Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of d

Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy.

Early-onset idiopathic growth hormone deficiency within KIGS.

Efficacy of Growth Hormone Treatment in Children with Type 1 Diabetes Mellitus and Growth Hormone Deficiency-An Analysis of KIGS Data.

Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease

Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone

Final height in children with medulloblastoma treated with growth hormone

Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database

Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data fr

Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome

Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.

Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone

Insulin-like growth factors as diagnostic tools in growth hormone deficiency during childhood and adolescence: the KIGS experience.

Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data

Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.

Magnetic resonance imaging of CNS in 15,043 children with GH deficiency in KIGS (Pfizer International Growth Database).

Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.

Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables

Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis an

Predicting growth in response to growth hormone treatment

Predicting the response to growth hormone treatment in short children with chronic kidney disease

Prediction model of total pubertal growth in idiopathic growth hormone deficiency: analysis of data from KIGS.

Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database) ⬇️

Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).

Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment

Secular Trends on Birth Parameters, Growth, and Pubertal Timing in Girls with Turner Syndrome.

Short Children with CHARGE Syndrome: Do They Benefit from Growth Hormone Therapy?

Stimulant use and its impact on growth in children receiving growth hormone therapy: an analysis of the KIGS International Growth Database.

The Basis for Optimising Growth with Growth Hormone Usage in Children with Idiopathic Short Stature: Analysis of Data from KIGS (Pfizer International Growth Study Database) ⬇️

The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency

Three-year growth response to growth hormone treatment in very young children born small for gestational age-data from KIGS.

Towards optimal treatment with growth hormone in short children and adolescents: evidence and theses

Using a spontaneous profile rather than stimulation test makes the KIGS idiopathic growth hormone deficiency model more accessible for clinicians.

Weight gain in Turner Syndrome: association to puberty induction? - longitudinal analysis of KIGS data